Revenio Group

Manufacturing · Finland · 201-500 Employees

View Company Info for Free

Overview

Headquarters

Äyritie 22, Vantaa, Uusimaa, 01510, Finl...

Phone Number

+358 205253301

Revenue

$103.9 Million

Stock Symbol

REG1V

Industry

Manufacturing Medical Devices & Equipment Holding Companies & Conglomerates
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Revenio Group

Revenio, a health technology group operating in the international markets, is one of the global leaders in ophthalmic appliances. The Revenio Group consists of Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, CenterVue Inc, Revenio Research Oy and Oscare Medical Oy. The common denominators of Revenio's business operations include patient-oriented screening, follow-up and the global need to make cost savings through preventive health care. Revenio seeks vigorous growth in health technology. Revenio aims to develop even more efficient and easily adopted methods for the early-stage detection of diseases with significance for public health. The aim is to improve the quality of life through health technology solutions that enable more effective diagnostics. Revenio Group's focus is on the early detection of glaucoma, diabetic retinopathy and macular degeneration, and the monitoring of these during the treatment process. Revenio Research concentrates on the commercializaRead more
Revenio Group's Social MediaPopular SearchesRevenio Group CorpRevenio Group OyjRevenio GroupRevenio ResearchSIC Code 38,384NAICS Code 33,339Ticker HEL: REG1VShow more

Is Revenio Group your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Revenio Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Revenio Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Revenio Group.

Revenio Group Tech Stack

A closer look at the technologies used by Revenio Group

Most Recent Scoops

Left Company
Executive Move
Executive Moves, Left Company
Earnings
Revenio Group has withdrawn its financial guidance for the current period, with new guidance to be issued following the completion of the Visionix acquisition and the recognition of associated one-off costs.
Earnings
Revenio Group has reported combined unaudited pro forma net sales of EUR 153 million and adjusted EBITDA of EUR 48 million for the last fiscal year, reflecting the combined financials of Revenio and Visionix prior to the completion of the acquisition; purchase price allocation and related depreciation and amortization figures will be published as part of Q2 results.
Earnings, Finance
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Left Company
Executive Move
Executive Moves, Left Company
See more scoops

Revenio Group News & Media

  • Revenio Group Oyj's Dividend Analysis

    As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Revenio Group Oyj's dividend performance and assess its sustainability. What Does Revenio Group Oyj Do?
  • Revenio Group Corporation: Managers' Transactions

    Revenio Group Corporation, Stock Exchange Release, September 18, 2020 at 12.00 Revenio Group Corporation - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Rönkä Pekka Position: Member of the Board/Deputy member (X) Legal person Issuer: Revenio Group Corporation LEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATION Reference number: 743700I27E0FWSXLKK04_20200918104822_2 ___________________________________________
  • Revenio Group Corporation: Managers' Transactions

    Revenio Group Corporation, Stock Exchange Release, September 3, 2020 at 16.00 Revenio Group Corporation - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Karvo Tomi Position: Other senior manager (X) Legal person Issuer: Revenio Group Corporation LEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATION Reference number: 743700I27E0FWSXLKK04_20200903154741_2 ____________________________________________ Transaction d
Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Revenio Group

What is Revenio Group's stock symbol?
Revenio Group's stock symbol is REG1V
What is Revenio Group's official website?
Revenio Group's official website is www.reveniogroup.fi
What is Revenio Group's Revenue?
Revenio Group's revenue is $103.9 Million
What is Revenio Group's SIC code?
Revenio Group's SIC: 38,384
What is Revenio Group's NAICS code?
Revenio Group's NAICS: 33,339
How many employees does Revenio Group have?
Revenio Group has 201-500 employees
What industry does Revenio Group belong to?
Revenio Group is in the industry of: Manufacturing, Medical Devices & Equipment, Holding Companies & Conglomerates
What companies has Revenio Group acquired?
Revenio Group has acquired the companies: VISIONIX, Latham & Phillips Ophthalmic, iCare
What technology does Revenio Group use?
Some of the popular technologies that Revenio Group uses are: Microsoft Azure, Adobe Typekit, Microsoft 365, Google Tag Manager
How do I contact Revenio Group?
Revenio Group contact info: Phone number: +358 205253301 Website: www.reveniogroup.fi
What does Revenio Group do?

Revenio, a health technology group operating in the international markets, is one of the global leaders in ophthalmic appliances. The Revenio Group consists of Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, CenterVue Inc, Revenio Research Oy and Oscare Medical Oy. The common denominators of Revenio's business operations inclu... de patient-oriented screening, follow-up and the global need to make cost savings through preventive health care. Revenio seeks vigorous growth in health technology. Revenio aims to develop even more efficient and easily adopted methods for the early-stage detection of diseases with significance for public health. The aim is to improve the quality of life through health technology solutions that enable more effective diagnostics. Revenio Group's focus is on the early detection of glaucoma, diabetic retinopathy and macular degeneration, and the monitoring of these during the treatment process. Revenio Research concentrates on the commercialization of systems supporting the diagnosis of and treatment planning for skin cancer and asthma.Read More

What are Revenio Group social media links?
Revenio Group Linkedin page Revenio Group Twitter page
Is Revenio Group a public company?
Yes, Revenio Group is a public company and is traded under the symbol REG1V
See more information about Revenio Group

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.